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K e y  M e s s a g e s 
1. The overall and type-specific human 
papillomavirus (HPV) prevalence differed 
between Hong Kong and Guangzhou healthy 
women. The prevalence of HPV was significantly 
higher in Guangzhou than Hong Kong women. 
Younger women had significantly higher risk of 
HPV infection. 
2. HPV16 remained the most common type detected 
in both regions; the frequency increased with 
increasing disease severity. The prevalence of 
HPV58 and HPV52 was relatively high in women 
with normal cervix and precancerous lesions. 
Human papillomavirus status in southern 
Chinese women
Introduction
Human papillomavirus (HPV) is a sexually 
transmitted pathogen that plays an important role 
in the pathogenesis of precancerous cervical lesions 
and cervical cancer.1 The prevalence of HPV types 
in Hong Kong differs from that in Sichuan, China. 
Cross-border travel and marriage between people in 
Hong Kong and Guangzhou have increased greatly, 
as has the potential for disease transmission. 
 Integration of HPV correlates with poor 
response to treatment and poor disease-free survival 
in cervical cancer.2 Integration usually causes 
deletion and/or disruption of the E2 gene of the HPV. 
In this study, we aimed to determine (1) the spectrum 
and prevalence of HPV in healthy women in Hong 
Kong and Guangzhou, and (2) whether integration 
of the high-risk HPV16 and HPV58 genomes in the 
host is associated with progressive severity of the 
precancerous cervical lesion and cervical cancer. 
Methods
This cross-sectional study was approved by the 
local institutional review board and conducted from 
October 2006 to September 2008, in collaboration 
with the Department of Obstetrics and Gynaecology 
and Department of Pathology of The University of 
Hong Kong, the Family Planning Association of 
Hong Kong, and the Department of Obstetrics and 
Gynaecology of the Second Affiliated Hospital, Sun 
Yet-Sen University, Guangzhou, Guangdong, China.
 The prevalence of HPV and type-specific 
infections in healthy women and women with 
precancerous lesions and cervical cancer were 
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compared between Hong Kong and Guangzhou. The 
association between co-factors and the risk of HPV 
infection was analysed. The integrations of HPV16 
and HPV58 viral DNA in host genomes were assessed 
and the clinical significance was determined. 
 Cytology samples of 1280 and 1273 healthy 
women in Hong Kong and Guangzhou were 
collected, respectively. The exfoliated cervical cells 
were collected by ThinPrep (Hologic, Bedford, MA, 
USA) in Hong Kong or liquid-based cervical cytology 
test in Guangzhou. In addition, 438 and 204 samples 
of cervical precancerous lesions and cervical cancers 
were retrospectively selected in the two regions, 
respectively.
 A Hybribio DNA extraction kit (Hybribio, 
Hong Kong) and QIAamp DNA FFPE Tissue Kit 
(Qiagen, Hilden, Germany) were used for DNA 
extraction from the cytological remnants and the 
paraffin-embedded tissues, respectively. Genotyping 
of HPV was performed using the GenoArray HPV 
genotyping test (Hybribio), which is a polymerase 
chain reaction (PCR)-based assay that is capable of 
amplifying 21 HPV genotypes, including 13 high-
risk types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 
and 68) and nine other-risk types. 
 The HPV viral DNA integration was determined 
by quantitative real-time fluorescent PCR with five 
sets of E2 and one set of E6 primers for HPV16 and 
HPV58. The proportion of integrated value was 
calculated by the ratio of E2 value (episomal) to E6 
value (episomal and integrated). 
Results
Of the 1280 and 1273 cytology samples from Hong 
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Kong and Guangzhou women, respectively, 1245 
(97.3%) and 1209 (95.0%) had normal cytology. 
The age-adjusted HPV prevalence was significantly 
lower in Hong Kong than Guangzhou women (5.6% 
[89/1245] vs 10.1% [163/1209], Table 1), particularly 
in the three younger age-groups (Fig). The prevalence 
of HPV infection varied between age-groups in the 
two regions. 
 In Hong Kong, the HPV prevalences in women 
with low-grade cervical intraepithelial neoplasia 
(LG CIN), high-grade CIN (HG CIN), and cervical 
cancer were 22.4%, 30.8%, and 40.2%, respectively. 
In Guangzhou, the corresponding prevalences 
were 6.0%, 28.9%, and 39.2%, respectively. The HPV 
prevalence in women with LG CIN was significantly 
higher in Hong Kong than Guangzhou (P<0.001). 
The rate for age-adjusted multiple HPV infection 
was 1.8% in women with normal cervix for both 
regions, accounting for 33.7% and 15.3% of HPV-
positive cases in Hong Kong and Guangzhou 
cohorts, respectively (P=0.001). 
 In Hong Kong, HPV16 was most commonly 
identified in women with normal cytology, HG 
CIN, and cervical cancer, whereas HPV58 was most 
commonly identified in women with LG CIN. In 
Guangzhou, HPV16 was most commonly identified 
in women with HG CIN and cervical cancer, whereas 
HPV52 and HPV31 were most commonly identified 
in women with normal cytology and LG CIN. HPV16, 
52 and 58 were the most common high-risk types 
detected in women with normal cytology in both 
regions. The frequency of HPV16 in women with 
normal cervix and cervical cancer was significantly 
higher in Hong Kong than in Guangzhou (P=0.015 
and P=0.036, respectively). The frequency of HPV16 
increased with an increase of disease severity. The 
frequencies of HPV58 and 52 were higher in women 
with normal cervix and precancerous lesion in both 
regions.
 Age was a risk factor only in Hong Kong 
women younger than 29 years, compared with other 
age-groups (P=0.009). Previous Pap smear test 
was another risk factor for women in Hong Kong 
(P=0.037). Women with a previous abnormal Pap 
smear test also had significantly higher HPV infection 
(P=0.021). In Guangzhou, women with previous 
abnormal cytological findings also had increased risk 
* P=0.01 to <0.05, Chi-squared test
† P=0.001 to <0.01, Chi-squared test
‡ P<0.001, Chi-squared test
TABLE 1.  Comparison of the prevalence of human papillomavirus (HPV) infections in Hong Kong and Guangzhou women
HPV prevalence Hong Kong (% positive) Guangzhou (% positive)
Normal 
(age-
adjusted)
Low-grade 
cervical 
intraepithelial 
neoplasia
High-grade 
cervical 
intraepithelial 
neoplasia
Cervical 
cancer
Normal 
(age-
adjusted)
Low-grade 
cervical 
intraepithelial 
neoplasia
High-grade 
cervical 
intraepithelial 
neoplasia
Cervical 
cancer
Overall prevalence 5.6‡ 22.4‡ 30.8 40.2 10.1‡ 6.0‡ 28.9 39.2
Multiple infection 1.8 1.9 0.9 1.0 1.8 0 1.8 2.0
Multiple infection among HPV-
positive
33.7† 8.3 2.8 2.4 15.3† 0 6.1 5.0
High-risk HPV 4.0‡ 31.0† 28.2 40.2 7.6‡ 5.0† 23.7 39.2
High-risk types among HPV-
positive
71.9 79.2 91.7 100 75.5 83.3 81.8 100
Type-specific (% HPV-positive)
HPV16 23.6* 16.7 27.8 56.1* 11.0* 16.7 36.4 77.5*
HPV18 14.6* 12.5 0* 22.0 4.9* 0 15.2* 17.5
HPV31 0‡ 0 13.9* 4.9 16.6‡ 33.3 0* 0
HPV52 19.1 20.8 13.9 7.3 23.9 33.3 9.1 0
HPV58 20.2* 29.2† 27.8 9.8 10.4* 0† 12.1 5.0
Total (5 types) 77.5 79.2 83.4 100 66.8 83.3 72.8 100
FIG.  Age-adjusted human papillomavirus (HPV) infection 
prevalences in five age-groups in Hong Kong and Guangzhou 
women.
* In Hong Kong, the prevalence of HPV infection is 
significantly lower in the age-group of 40-49 years than that 
of 20-29 years and ≥60 years (P<0.05)
† The prevalence of HPV infection is significantly higher in 
Guangzhou than Hong Kong women in the age-groups of 
20-29 years (P<0.001), 30-39 years (P<0.001), and 40-49 
years (P=0.009)
‡ In Guangzhou, the prevalence of HPV infection is 
significantly higher in the age-groups of 20-29 years, 30-39 
years, and 40-49 years than in the other groups (P<0.05)
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of HPV infection (P=0.044). Two sexual behaviour 
variables (lifetime number of sexual partners and 
age at first sexual intercourse) were associated with 
the risk of HPV infection. In Guangzhou, the risk of 
HPV infection was significantly higher in women 
with ≥3 than 1-2 lifetime sexual partners (P<0.001). 
In Hong Kong, women having first sexual intercourse 
before the age of 20 years had higher risk than those 
having first sexual intercourse after the age of 21 
years (P=0.043). After multivariable analysis, only 
the lifetime number of sexual partners remained a 
significant factor in Guangzhou women (Table 2). 
No association was noted with variables of gravidity, 
use of condom or oral contraceptive, history of 
sexually transmitted diseases, and smoking.
 The complete episomal form was found in 
only 3/110 (2.7%) HPV16- and 4/48 (8.3%) HPV58-
positive samples. HPV16 integration and HPV58 
integration were detected in 107 and 44 samples, 
respectively; 30 (27.3%) HPV16-positive samples 
and only one (2.1%) HPV58-positive sample showed 
complete integration. No significant difference in 
the integration patterns of HPV16 or HPV58 with 
regard to the various grades of cervical lesions was 
noted. The distribution and frequency of HPV16 or 
HPV58 DNA integration were similar between the 
Hong Kong and Guangzhou regions. 
Discussion
In Guangzhou, the age-adjusted HPV infection rate 
was 10.1% in women with normal cytology, which is 
TABLE 2.  Multiple logistic regression for risk factors of human papillomavirus (HPV) infection in Hong Kong and Guangzhou women
Variable Hong Kong Guangzhou
No. HPV-
positive (%)
OR (95% CI) P value No. HPV-
positive (%)
OR (95% CI) P value
Age (years) 0.025 0.626
20-29 248 10.9 1 233 15.0 1
30-39 243 4.9 0.53 (0.24-1.15) 237 14.3 1.48 (0.79-2.77)
40-49 249 3.2 0.37 (0.14-1.00) 236 12.7 1.19 (0.61-2.33)
50-59 250 7.2 0.77 (0.29-2.01) 253 13.8 1.55 (0.77-3.10)
≥60 255 9.4 1.32 (0.50-3.48) 250 11.6 1.21 (0.59-2.49)
Previous Pap smear test 0.038 0.087
Yes 1040 6.4 1 377 11.4 1
No 205 10.7 0.49 (0.25-0.96) 832 14.4 0.71 (0.48-1.05)
Lifetime number of sexual partner 0.973 0.015
1 868 6.8 1 1039 12.4 1
2 185 7.0 0.92 (0.45-1.88) 123 13.8 1.21 (0.67-2.18)
≥3 192 8.9 0.98 (0.46-2.09) 46 34.8 3.20 (1.45-7.04)
Age at first sexual intercourse (years) 0.236 0.701
≤20 430 17.8 1 176 14.2 1
21-25 510 5.3 0.55 (0.30-1.00) 643 14.3 1.31 (0.76-2.26)
26-35 292 6.2 0.62 (0.30-1.28) 385 11.7 1.11 (0.58-2.10)
≥36 13 7.7 1.14 (0.13-10.26) 5 20.0 1.64 (0.17-16.20)
Sexually transmitted disease history 0.95 0.368
Never 1214 7.2 1 1170 13.2 1
Ever 16 6.3 0.94 (0.12-7.52) 17 29.4 1.74 (0.52-5.76)
Oral contraceptive use 0.197 0.588
Never 551 6.5 1 1031 13.2 1
Ever 683 7.6 1.38 (0.85-2.26) 177 14.6 1.14 (0.71-1.84)
Condom use 0.152 0.888
Never or rare 672 8.3 1 877 13.7 1
Regular 549 5.6 0.69 (0.42-1.15) 318 12.9 0.97 (0.64-1.47)
Gravidity 0.065 0.348
0 354 6.5 1 86 20.9 1
1-2 455 8.4 1.87 (0.92-3.80) 548 12.4 0.55 (2.80-1.08)
3-4 334 7.2 1.25 (0.52-3.00) 455 13.6 0.52 (0.24-1.09)
≥5 100 4.0 0.55 (0.45-2.04) 120 12.5 0.52 (0.21-1.28)
Smoking 0.808 0.958
Never 1105 6.7 1 1173 13.3 1
Former 72 8.3 1.09 (0.43-2.77) 17 17.6 1.22 (0.32-4.65)
Current 68 11.8 1.34 (0.56-3.21) 19 21.1 1.01 (0.30-3.49)
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similar to other regions of China.3 In Hong Kong, the 
rate was significantly lower at 5.6%. In Guangzhou, 
younger women (age <39 years) had a significantly 
higher infection rate than older women. In Hong 
Kong, the highest infection rate was in women in 
the age-groups of 20-29 years and >60 years. The 
difference in HPV prevalence between the two 
regions could be due to differences in the living 
environments and life-styles. 
 In Hong Kong, the crude HPV infection rate in 
healthy women was 7.2%, which was lower than that 
in our previous study.3 The difference could be due 
to the different HPV detection methods used. The 
Hybribio HPV genotyping test detects only 21 HPV 
genotypes, whereas the DNA sequencing method 
detects more genotypes. In CIN and cancer samples, 
the HPV prevalence was also significantly lower in 
our study than in the previous study. These CIN and 
cancer samples were paraffin-embedded tissues, and 
the DNA extracted was frequently fragmented. As 
the primers in the Hybribio HPV genotyping test 
amplify 450 bp long products, a number of HPV-
positive samples and genotypes might have been 
missed. 
 HPV16 remained the most common high-risk 
type detected in both Hong Kong and Guangzhou, 
and HPV18 was the second most common type in 
cervical cancer. The frequency of HPV16 increased 
with increased disease severity. Consistent with 
our previous finding,3 high prevalence of HPV58 
and HPV52 was noted, especially in the normal and 
precancerous groups. 
 Having previous cervical cancer screening 
was an independent risk factor associated with 
HPV infection in Hong Kong women, but not in 
Guangzhou women. This might be due to the small 
sample size. Only one third of women in Guangzhou 
had a previous Pap smear test, compared with >80% 
of women in Hong Kong. This might have contributed 
to the higher incidence of HPV infection in healthy 
women in Guangzhou. Cervical cancer screening 
should be promoted to prevent cervical disease. 
 In Guangzhou, women having ≥3 lifetime 
sexual partners had increased risk of HPV infection. 
In Hong Kong, sexual behaviour factors had no such 
association. A population-based study in Shanxi, 
China also found no such association.4 
 Integration of HPV16 into the host DNA has 
been proposed as a potential marker of cervical 
neoplastic progression.2 E2 disruption may occur in 
any part of the E2 genome, which spans about 1000 
bp. To optimise the test sensitivity, we designed five 
sets of primers to flank the entire E2 sequence for 
HPV16 or HPV58 genes. Most of the HPV16-positive 
samples harboured mixed forms of viral integration 
products. The mixed integrated form of HPV16 was 
the most prevalent physical state in normal cytology, 
and the complete integrated form occurred in two 
thirds of LG CIN cases. Similar findings have also 
been reported.5 
 In this study, the prevalent physical state of 
HPV58 integration was the mixed integrated form. 
HPV58 commenced early during the course of lesion 
progression, but this might not be essential for the 
development of HPV58-related cervical cancer. 
 Significant differences in HPV16 and HPV58 
integration patterns were not observed between 
Hong Kong and Guangzhou women, although 
the prevalence for both types was significantly 
higher in Hong Kong women. Clinical association 
with abnormal cytology was not observed with 
integration. This may have been due to the limited 
number of mixed swap samples and archived paraffin 
samples analysed. The significant portion of normal 
cytology samples harbouring the mixed integration 
form suggested that HPV16 or HPV58 integration 
occurred early in the cervical transformation 
process leading to deregulated expression of the E6/7 
oncoproteins resulting in major genomic instability 
in HPV-infected cells. Therefore, detection of viral 
DNA integration may have prognostic value in the 
prediction of cervical lesion progression, especially 
in women without detectable cervical abnormality.
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